Dabur India units face lawsuits in US, Canada alleging products caused cancer
Indian multinational consumer goods company, Dabur India Ltd met with twin controversies in both India and abroad, as it has received a GST Rs 321 crore notice in India, and on the other hand, its subsidiaries has been subjected to series of lawsuits in U.S. and Canada by the consumers over the allegations that hair relaxer products cause had caused ovarian cancer, uterine cancer and other...
Indian multinational consumer goods company, Dabur India Ltd met with twin controversies in both India and abroad, as it has received a GST Rs 321 crore notice in India, and on the other hand, its subsidiaries has been subjected to series of lawsuits in U.S. and Canada by the consumers over the allegations that hair relaxer products cause had caused ovarian cancer, uterine cancer and other health issues.
In India, Dabur received a notice from the Government regarding the payment of GST short paid / not paid amounting to Rs. 3,20,60,53,069/- along with applicable interest and penalty.
For more details, check out the link given below:
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd